SGK1 and posterior cortical atrophy: Together, the results from these preclinical studies suggest that targeting this newly identified circRAB3IP/miR-133a-3p/miR-133b/SGK1 signaling pathway may help in the development of a better therapy to restore the Enz sensitivity of PCa cells.